| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/09/1996 | US5505784 Polycondensates which contain tartaric acid derivatives, processes for their preparation and use thereof |
| 04/09/1996 | US5505726 Article of manufacture for the photodynamic therapy of dermal lesion |
| 04/09/1996 | US5505715 Iontophoretic transdermal delivery of deoxyspergualin compounds |
| 04/09/1996 | US5505306 Package structure of drug-containing pressure-sensitive adhesive sheet |
| 04/09/1996 | CA1338235C Esters of alginic acid |
| 04/07/1996 | CA2133789A1 Immobilized-cell carrageenan bead production and a brewing process utilizing carrageenan bead immobilized yeast cells |
| 04/04/1996 | WO1996009829A1 Improved topical carriers for mucosal applications |
| 04/04/1996 | WO1996009816A1 Medicaments |
| 04/04/1996 | WO1996009815A1 Starch products as tabletting excipient, method for preparing same, and method for making tablets |
| 04/04/1996 | WO1996009814A1 Spray-dried microparticles as therapeutic vehicles |
| 04/04/1996 | WO1996009813A1 Diketopiperazine-based delivery systems |
| 04/04/1996 | WO1996009812A1 Phospholipid- and cholesterol-free aqueous composition for topical application to the skin |
| 04/04/1996 | WO1996009793A1 Harmonic ultrasound imaging with microbubbles |
| 04/04/1996 | DE19536246A1 Pharmaceutical compsn. for spraying as drops |
| 04/04/1996 | DE19536245A1 Pharmaceutical compsn. for spraying as drops |
| 04/04/1996 | DE19536244A1 Pharmaceutical compsn. for spraying as drops |
| 04/04/1996 | CA2199954A1 Spray-dried microparticles as therapeutic vehicles |
| 04/03/1996 | EP0704222A1 In vivo degradable medical device, composition and method for its production and process for its decomposition |
| 04/03/1996 | EP0704220A1 Use of medicine containing beta interferon |
| 04/03/1996 | EP0704216A1 Gel-like pharmaceutical compositions containing chondroitin sulfate salts suitable for oral administration |
| 04/03/1996 | EP0704214A1 Process for obtaining pure nizatidine |
| 04/03/1996 | EP0704212A2 Method of minimizing hepatic reperfusion injury |
| 04/03/1996 | EP0704209A1 Transdermally active pharmaceutical composition containing 5-aminolaevulinic acid |
| 04/03/1996 | EP0704208A2 Coating and binder compositions for pharmaceutical forms and pharmaceutical forms prepared therewith |
| 04/03/1996 | EP0704207A2 Thermoplastic resin for enteric pharmaceutical coating |
| 04/03/1996 | EP0704206A1 Pharmaceutical composition |
| 04/03/1996 | EP0704199A1 Transfusion container, transfusion preparation, and comprehensive vitamin-containing high-calorie transfusion preparation |
| 04/03/1996 | EP0703802A1 Intravaginal delivery system |
| 04/03/1996 | EP0703779A1 Compressible enzyme powder |
| 04/03/1996 | EP0703777A1 Intra-uterine ring for the release of an active agent, such as a hormone, and an introducer |
| 04/03/1996 | EP0605483B1 Propellant for aerosols and dosing aerosols |
| 04/03/1996 | EP0532611B1 Process for the manufacture of porous cellulose matrices |
| 04/03/1996 | EP0526561B1 Composition for transdermal penetration of medicaments |
| 04/03/1996 | EP0490891B1 Drug containing matrix |
| 04/03/1996 | EP0478715B1 Targeted liposomes and methods for liposome-protein coupling |
| 04/03/1996 | CN1119834A A plaster working as a dosing device |
| 04/03/1996 | CN1119831A Phase shift colloids as ultrasound contrast agents |
| 04/03/1996 | CN1119829A Vaccine compositions containing 3-O deacylated monophosphoryl lipid a |
| 04/03/1996 | CN1119828A Cross-linked amylose as a binder/disintegrant in tablets |
| 04/03/1996 | CN1119628A High-efficiency water purifying treatment device |
| 04/03/1996 | CN1119541A Gargle made of sarcandra glabra |
| 04/03/1996 | CN1119531A A stably storable and readily water soluble composition of cephalosporin for injections |
| 04/03/1996 | CN1119530A Methods of use for inhibiting bone loss and lowering serum cholesterol |
| 04/03/1996 | CN1119528A A contraceptive for use by a male |
| 04/02/1996 | USRE35200 Coating for pharmaceutical dosage forms |
| 04/02/1996 | US5504216 Method for reparing an amorphous sulfonamide |
| 04/02/1996 | US5504113 Enhancement of benzalkonium chloride preservative activity in formulations containing an incompatible drug |
| 04/02/1996 | US5504105 In oily vehicles that promote absorption enabling dosage to be simplified |
| 04/02/1996 | US5504102 Solution of teniposide, paclitaxel, or camptothecin and derivatives antitumor agent and polyethoxylated castor oil mixed with acid to lower the carboxylate anion content; shelf-life, by-product inhibition |
| 04/02/1996 | US5504099 Storage stable aqueous diuretic solution containing azosemide salt of organic amine and biocompatible organic solvent |
| 04/02/1996 | US5504068 Topical preparations containing cyclosporin |
| 04/02/1996 | US5504065 Agent for treating or preventing AIDS using human urine trypsin inhibitor |
| 04/02/1996 | US5503862 Reducing temperature by mixing in fructose, maltodextrin and/or polydextrose |
| 04/02/1996 | US5503853 Prophylactic and therapeutic applications of peroxidases |
| 04/02/1996 | US5503852 Cyclodimerization of amino acids, precipitation of microparticles; for encapsulating drugs |
| 04/02/1996 | US5503851 Microencapsulation of water-soluble medicaments |
| 04/02/1996 | US5503850 Large unilamellar vesicles encapsulating a plasminogen activator |
| 04/02/1996 | US5503848 Topical dose of sterile, slow-release, lyophilized non-crosslinked hyaluronic acid ester; wound healing agents, ears |
| 04/02/1996 | US5503847 Hydrocolloid wound gel |
| 04/02/1996 | US5503846 Coating of base retards reaction between edible acid and acid sensitive pharmaceutically active agent which lessens activity of dosage form; antiulcer agents |
| 04/02/1996 | US5503845 Produced by intensive moistening of active ingredient with more than 30 weight per cent water in a granulator with maximum energy input |
| 04/02/1996 | US5503844 Foam laminate transdermal patch |
| 04/02/1996 | US5503843 Transdermal delivery of alpha adrenoceptor blocking agents |
| 04/02/1996 | US5503838 Iodine barrier teat dip |
| 04/02/1996 | US5503833 VP6 encapsulated drug delivery |
| 04/02/1996 | US5503827 Process for the production of multi-dose pharmaceutical preparations containing isolated or recombinantly produced human protein for infusion or injection purposes |
| 04/02/1996 | US5503746 Thin, self-interlocking, tactic polyvinyl alcohol, retaining geometric configuration |
| 04/02/1996 | US5503723 Placing nanoparticle dispersion between two electrodes, applying electrical field, removing portion of dispersion having particle size distribution less than original |
| 04/02/1996 | US5503673 Apparatus for dip coating product |
| 03/31/1996 | CA2159552A1 Sustained-release preparation |
| 03/29/1996 | CA2159288A1 Aqueous nasal suspension |
| 03/28/1996 | WO1996009070A1 Use of starch for transdermal applications |
| 03/28/1996 | WO1996009056A1 Process of making dosage units by wet granulation |
| 03/28/1996 | WO1996009042A1 Compositions and methods for the control of smoking |
| 03/28/1996 | WO1996009038A2 Alteration of activity and/or levels of haem-oxygenase to control inflammation |
| 03/28/1996 | WO1996009037A1 Method of producing a lyophilized liposome product |
| 03/28/1996 | WO1996009036A1 Therapeutic vitamin-calcium combination in unitary galenic tablet form, method for preparing same and use thereof |
| 03/28/1996 | CA2200755A1 Compositions and methods for the control of smoking |
| 03/28/1996 | CA2199018A1 Method of producing a lyophilized liposome product |
| 03/27/1996 | EP0702960A1 Liquid globulin composition for intravenous injection, process for producing the same, and method of inhibiting globulin dimer increase in said composition |
| 03/27/1996 | EP0702959A1 Cross-linked gelatin gel preparation containing basic fibroblast growth factor |
| 03/27/1996 | EP0702958A1 Vaginal preparation containing physiologically active peptide |
| 03/27/1996 | EP0702957A1 Extracts of St.John's wort |
| 03/27/1996 | EP0702954A2 Calcium dietary supplement |
| 03/27/1996 | EP0702953A2 Dosage form comprising alpha-lipoic acid or solid salts thereof with improved bioavailability |
| 03/27/1996 | EP0702723A1 Biocompatible implant for the expression and secretion in vivo of a therapeutical compound |
| 03/27/1996 | EP0702568A1 An emollient composition |
| 03/27/1996 | EP0702567A1 Methods and compositions for aiding periodontal tissue regeneration |
| 03/27/1996 | EP0702565A1 CATALASE-BASED ANTI-$i(HELICOBACTER PYLORI) IMMUNISING COMPOSITION |
| 03/27/1996 | EP0702563A1 Compositions and methods for treating cancer and hyperproliferative disorders |
| 03/27/1996 | EP0702562A1 Cyclosporin-containing powder composition |
| 03/27/1996 | EP0702557A1 Therapeutic inhibitor of vascular smooth muscle cells |
| 03/27/1996 | EP0702552A1 Solid fat nanoemulsions as drug delivery vehicles |
| 03/27/1996 | EP0702551A1 Compositions and methods for reparation and prevention of fibrotic lesions |
| 03/27/1996 | EP0702540A1 Condom with transdermal vasodilator |
| 03/27/1996 | EP0693884A4 Encapsulation compositions |
| 03/27/1996 | EP0662836A4 Germicidal detergent-iodine compositions having reduced detergent content. |
| 03/27/1996 | EP0586476B1 Method of producing reproducible particles |
| 03/27/1996 | EP0498841B1 Bioadhesive composition and patch |
| 03/27/1996 | EP0473687B1 Stable pharmaceutical composition of 3-(hydroxymethyl)-5,5-diphenylhydantoin disodium phosphate ester |